At booth #506 (Expo. X5), Samsung is displaying medical equipment based on its ‘AccE’ (Access, Accuracy and Efficiency) strategy, which aims to change the industry by incorporating innovations in physical access to provide care wherever needed. Samsung also seeks to improve accuracy in diagnosis with advanced algorithms and efficiency with advanced display, UX and information management technology developed by Samsung Electronics.

“Samsung is committed to medical advancements for both diagnostic solutions and patient care. We will continue to develop optimized medical equipment to healthcare providers by combining our key values in the pursuit of Access, Accuracy and Efficiency,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison.

Within ultrasound systems, Samsung has made great achievements in Obstetrics and Gynecology and will continue to expand its portfolio to the radiology segment. At ECR 2018, Samsung will present upgraded ultrasound systems including:

• RS85, Samsung’s advanced premium ultrasound system for radiology that provides enhanced image quality and convenience for medical and radiology professionals. The RS85 features MV-Flow technology, which detects blood flow in the microvascular, and S-Shearwave Imaging, which provides new indicators for clinical diagnosis by quantifying the elasticity of tissue. The S-Fusion function extends analysis from the abdomen to the prostate, and also allows coordination and simultaneous comparative analysis of images from other modalities such as MRI and CT for easy and fast biopsy.

• HS70A with Prime, the high-end ultrasound system specifically designed to fit into a general ultrasound imaging setting from routine to complex. It features Arterial Analysis, which detects changes in vessels, providing measurement values such as stiffness. The S-Shearwave and Realistic Vue are additional features that improve image quality.

Samsung will also introduce digital radiography solutions that manage the dose for patients and meet the needs of healthcare providers, including:

• GC85A, which provides outstanding images that boost diagnostic confidence equipped with technologies such as S-Detector and S-Align. The device adopts Low Dose technology for enhanced patient safety. Samsung recently cleared in the U.S. FDA for 50% dose reduction in adults’ chest exams, using GC85A with the new imaging engine S-Vue3.02.

• GM85, a lighter version of original GM85 will be displayed. The weight is reduced, but the functional benefits such as enhanced mobility and streamlined workflow are still retained. GM85 provides advanced patient care through leading edge imaging functions.

At the Beyond Experience Zone, visitors can learn about Samsung’s efforts in supporting radiologists in their diagnoses through various software technologies such as SimGrid^TM, Bone Suppression and Dose Reduction. In addition to superb medical equipment, healthcare providers can visit the Low Dose Campaign Zone and experience how low the radiation dose of GC85A is compared to real life radiation through the Low Dose Quiz.

Samsung Electronics’ subsidiary NeuroLogica will showcase innovative mobile CT OmniTom^®, which features an array of improvements from Samsung’s award-winning CereTom^® CT scanner. OmniTom^® is ideal for cranial procedures and is designed to deliver high-quality non-contrast CT, CT angiography and CT perfusion scans. The combination of its rapid scan time, ultra-small footprint and immediate image viewing makes OmniTom^® an indispensable tool for collecting real-time data on critically ill patients. Samsung will also show its spectral CT with Photon Counting Detector (PCD), the next generation of CT technology.

Samsung is also presenting a prototype of Extremity MRI, which is expected to be a game changer in the industry. It is designed to improve not only cost and space efficiency but also patient convenience, as it reduces the need for the whole body to be in the MRI device to scan extremity areas such as arms and legs.

In addition to showcasing its portfolio of comprehensive healthcare solutions, Samsung will be hosting two satellite symposia throughout the week at ECR. Samsung’s symposia will highlight the key trends and issues across ultrasound imaging and digital radiography technologies.

For more information on Samsung’s healthcare division, its subsidiaries and products, please visit https://www.samsunghealthcare.com/.

UOG is the official journal published by the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). The image that the publication selected represents a breakthrough for Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics. Its fetal echocardiography technology called 5D Heart Color allows a precise diagnosis of congenital heart disease.

The clinical image was obtained from a 26-week fetus with hypoplastic left heart and coarctation of the aorta, in which nine standard fetal echocardiography views with automatic labeling were displayed on a single screen.

The story behind the image can be found in a research paper led by Prof. Roberto Romero, Chief of the Perinatology Research Branch of the National Institute of Child Health and Human Development (NICHD)/National Institutes of Health in the U.S., and Prof. Lami Yeo, M.D., from the Department of Obstetrics and Gynecology at the Wayne State University School of Medicine in Detroit, U.S.

According to the research, the Picture of the Month illustrates how the cardiac diagnostic planes shown by 5D Heart Color (i.e. color Doppler FINE – Fetal Intelligent Navigation Echocardiography) allowed a precise diagnosis of hypoplastic left heart with coarctation of the aorta, and that such planes demonstrated evidence of abnormal fetal cardiac anatomy and hemodynamic flow.

The publication stated, “The characteristic features of this congenital heart defect were visualized in the seven echocardiography views. In the four-chamber view, the left side of the heart was severely hypoplastic with absent flow through the atretic mitral valve, and the aortic arch view showed a very narrow transverse aortic arch (coarctation) with reversed color Doppler flow in this area and the isthmus.”

Samsung’s 5D Heart Color provides nine different fetal echocardiography views containing clinically useful information about cardiac structure and function, including the three vessels and trachea view, four-chamber view, left and right ventricular outflow tract views, aortic arch view, and four others. In cases of congenital heart disease, since abnormal fetal cardiac anatomy and hemodynamic flow characteristics are depicted, this enhances the diagnostic potential of the technology. In addition, there is reduced operator dependency, and examination of the fetal heart is standardized and simplified.

As 5D Heart Color marks the second time Samsung Medison’s technology has been selected as Picture of the Month, (The company’s Crystal Vue also gained the honor in 2016) it’s an illustration of how Samsung Medison is continuing to establish its brand power in the global women’s health industry by providing technology with clinical value to medical professionals.

“It is exciting to see 5D Heart Color is being featured on the front cover of UOG, especially since the diagnostic accuracy of 5D Heart was presented at last month’s World Congress on Ultrasound in Obstetrics and Gynecology,” said Insuk Song, Vice President of the Health & Medical Equipment of Samsung Electronics. “Samsung will continue to focus on developing medical technology that can improve the detection of fetal congenital heart disease and contribute to saving more lives.”